In teenagers with childhood-onset chronic pain unrelated to chronic disease, poor sleep quality and depression were risk factors for substance use in young adulthood.
Dupixent significantly reduced itch and hive activity from baseline; 41% of patients achieved well-controlled disease status Confirmatory data to support U.S. regulatory resubmission by year-end; if ...